A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Glimepiride; Metformin

Criteria

Inclusion Criteria:

• Patient has type 2 diabetes mellitus

• Between the ages of 18 and 70

Exclusion Criteria:

• Patient has a history of type 1 diabetes mellitus or ketoacidosis.

• Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.

• Patient has had surgery within 30 days of starting the study or has planned major surgery during the study